Načítá se...
Functionally Improved Mesenchymal Stem Cells to Better Treat Myocardial Infarction
Myocardial infarction (MI) is one of the leading causes of death worldwide. Mesenchymal stem cell (MSC) transplantation is considered a promising approach and has made significant progress in preclinical studies and clinical trials for treating MI. However, hurdles including poor survival, retention...
Uloženo v:
| Vydáno v: | Stem Cells Int |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6286742/ https://ncbi.nlm.nih.gov/pubmed/30622568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/7045245 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|